Anthony J Weier

Array ( [id] => 3842462 [patent_doc_number] => 05707969 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor' [patent_app_type] => 1 [patent_app_number] => 8/480320 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9692 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707969.pdf [firstpage_image] =>[orig_patent_app_number] => 480320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3824538 [patent_doc_number] => 05759782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Cellular apoptosis susceptibility protein (CSP) and antisense CSP' [patent_app_type] => 1 [patent_app_number] => 8/480662 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 14143 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/759/05759782.pdf [firstpage_image] =>[orig_patent_app_number] => 480662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4220068 [patent_doc_number] => 06040296 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation' [patent_app_type] => 1 [patent_app_number] => 8/472527 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5802 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/040/06040296.pdf [firstpage_image] =>[orig_patent_app_number] => 472527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4174719 [patent_doc_number] => 06140552 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Production of recombinant polypeptides by bovine species and transgenic methods' [patent_app_type] => 1 [patent_app_number] => 8/476798 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 50 [patent_no_of_words] => 39040 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140552.pdf [firstpage_image] =>[orig_patent_app_number] => 476798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4230727 [patent_doc_number] => 06143291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Methods for modulating T cell survival by modulating bcl-X.sub.L protein level' [patent_app_type] => 1 [patent_app_number] => 8/481739 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 25682 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143291.pdf [firstpage_image] =>[orig_patent_app_number] => 481739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4025428 [patent_doc_number] => 05925802 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Functional reconstitution of SCID-bo mice with bovine fetal hematopoietic tissues' [patent_app_type] => 1 [patent_app_number] => 8/473373 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 3 [patent_no_of_words] => 5945 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925802.pdf [firstpage_image] =>[orig_patent_app_number] => 473373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696996 [patent_doc_number] => 05674486 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Cancer immunotherapy with carrier cells' [patent_app_type] => 1 [patent_app_number] => 8/473123 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4584 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674486.pdf [firstpage_image] =>[orig_patent_app_number] => 473123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3847537 [patent_doc_number] => 05766884 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Synthesis of functional human hemoglobin and other proteins in erythroid tissues of transgenic animals' [patent_app_type] => 1 [patent_app_number] => 8/466443 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 31 [patent_no_of_words] => 19599 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766884.pdf [firstpage_image] =>[orig_patent_app_number] => 466443 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884990 [patent_doc_number] => 05714345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Increased expression of a gene by a second transferred mammary gland specific sequence transgenic' [patent_app_type] => 1 [patent_app_number] => 8/472737 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 10181 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714345.pdf [firstpage_image] =>[orig_patent_app_number] => 472737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682872 [patent_doc_number] => 05643556 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Stimulation of tanning by DNA fragments or single-stranded DNA' [patent_app_type] => 1 [patent_app_number] => 8/493251 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4295 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643556.pdf [firstpage_image] =>[orig_patent_app_number] => 493251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3753547 [patent_doc_number] => 05843425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Transplantation and graft-versus-host-disease' [patent_app_type] => 1 [patent_app_number] => 8/461693 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13491 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/843/05843425.pdf [firstpage_image] =>[orig_patent_app_number] => 461693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4375754 [patent_doc_number] => 06303331 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Vertebrate apoptosis gene: compositions and methods' [patent_app_type] => 1 [patent_app_number] => 8/461511 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 31 [patent_no_of_words] => 29835 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303331.pdf [firstpage_image] =>[orig_patent_app_number] => 461511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3863974 [patent_doc_number] => 05762926 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system' [patent_app_type] => 1 [patent_app_number] => 8/464397 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 134 [patent_no_of_words] => 42020 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/762/05762926.pdf [firstpage_image] =>[orig_patent_app_number] => 464397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4161166 [patent_doc_number] => 06114598 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-05 [patent_title] => 'Generation of xenogeneic antibodies' [patent_app_type] => 1 [patent_app_number] => 8/464582 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 18 [patent_no_of_words] => 25461 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/114/06114598.pdf [firstpage_image] =>[orig_patent_app_number] => 464582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237205 [patent_doc_number] => 06143727 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Specific expression vectors and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/458240 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16419 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143727.pdf [firstpage_image] =>[orig_patent_app_number] => 458240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088153 [patent_doc_number] => 06162963 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Generation of Xenogenetic antibodies' [patent_app_type] => 1 [patent_app_number] => 8/462513 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 50 [patent_no_of_words] => 25308 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162963.pdf [firstpage_image] =>[orig_patent_app_number] => 462513 [rel_patent_id] =>[rel_patent_doc_number] =>)